Abivax Stock Quote ABVX - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Abivax SA (ABVX) Quote

Abivax SA (ABVX)

14.295

0.345

(2.47%)

Closed June 08 4:00PM

Delayed by 15 minutes

14.295

0.00

(0.00%)

After Hours: 4:37PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

14.295

Bid

13.60

Ask

22.43

Volume

6,404

13.715 Day's Range 14.50

0.00 52 Week Range 0.00

Market Cap

Previous Close

13.95

Open

13.90

Last Trade

Last Trade Time

Financial Volume

$ 90,324

VWAP

14.1044

Average Volume (3m)

-

Shares Outstanding

62,929,000

Dividend Yield

-

PE Ratio

-5.49

Earnings Per Share (EPS)

-2.35

Revenue

4.62M

Net Profit

-147.74M

Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.abivax.com

Headquarters

Paris, Paris, Fra

Founded

1970

Abivax SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ABVX. The last closing price for Abivax was $13.95. Over the last year, Abivax shares have traded in a share price range of $ 0.00 to $ 0.00.

Abivax currently has 62,929,000 shares outstanding. The market capitalization of Abivax is $811.78 million. Abivax has a price to earnings ratio (PE ratio) of -5.49.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting

PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CLEUChina Liberal Education Holdings Ltd	$ 3.1505 (55.97%)	17.88M
HUDAHudson Acquisition I Corporation	$ 16.6999 (52.51%)	635.96k
VEROVenus Concept Inc	$ 0.893101 (52.22%)	64.79M
HRYUHanryu Holdings Inc	$ 0.5047 (40.55%)	2.83M
HUDAUHudson Acquisition I Corporation	$ 15.77 (30.22%)	3.77k
DSYBig Tree Cloud Holdings Limited	1.9091 (-74.67%)	359.21k
BMEABiomea Fusion Inc	$ 4.14 (-63.27%)	11.22M
NBSTWNewbury Street Acquisition Corporation	$ 0.0374 (-32.00%)	174.15k
DHACUDigital Health Acquisition Corporation	$ 15.90 (-30.20%)	2.1k
SCNIScinai Immunotherapeutics Ltd	$ 2.97 (-28.41%)	706.54k
FFIEFaraday Future Intelligent Electric Inc	$ 0.602 (10.66%)	419.77M
PRSTPresto Technologies Inc	$ 0.09 (18.58%)	325.8M
SQQQProShares UltraPro Short QQQ	$ 9.32 (0.32%)	120.35M
CRKNCrown Electrokinetics Corporation	$ 0.0902 (3.20%)	119.61M
GERNGeron Corp	$ 4.60 (18.25%)	98.94M

JACKPOT

JACKPOT 39 seconds ago

The time he spends on boards and doing research on what people bought 4-5 years ago..... 🤣

L
O
S
E
R

bobby1151

bobby1151 48 seconds ago

Very welcome post - THANKS!!

Russ777

Russ777 2 minutes ago

No one pays any attention to him. He's a loser spending time trolling boards spewing immature diatribes.

jour_trader

jour_trader 3 minutes ago

I’m not sure if this is a delay tactic to buy more time from Purdue and/or looking to save money in legal costs.

oldstocks

oldstocks 3 minutes ago

2024 Nvidia Dell OneMind in November

https://www.nvidia.com/en-us/events/smart-city-expo-world-congress/

You go to the link, scroll down to Nvidia partners and click on Dell Technologies

Hall 1, C10
Featuring edge Al solutions with NVIDIA Jetson a

Monksdream

Monksdream 3 minutes ago

ZCMD new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/6/8/itkqhIMG_8649.gif

tedpeele

tedpeele 4 minutes ago

I think a "complete PDK" is wishful thinking and already gave my reasoning in response to KCC.

You and he are free to believe against both the evidence and common sense though.

..

Whalatane

Whalatane 4 minutes ago

Jas. Yes drug pricing in the US is " an absolute jungle " With discounts / rebates etc brand Vascepa can be as low as $1,625 a yr ( ICER report ) and generic V is estimated to be up to 20% less than that the introduction of generic icosapent ethyl resulted in a price reduction of about 20% co

theorysuit

theorysuit 4 minutes ago

The story is the same. Blame external nefarious forces instead of looking internal. They Can't they just reverse split and they are listed as the sheep suggest. And blame nasdaq and sec for their own backdealing violations. Smfh.

The_Gman

The_Gman 5 minutes ago

Have any Nebraskans reached out to U.S. Senator Deb Fischer's and Congressman Don Bacon's offices and see if they will provide an update on the $10 million? If nothing else, it might put it on someone's desk for a minute.

fink

fink 5 minutes ago

The interview yes, but filings and tensing current is basic house cleaning duties everyone expects.

All the interview did was put to rest a lot of scam talk.
It's easy for a CEO to say one thing, till it's shown in an official filing, just add to the dips.

I t

Monksdream

Monksdream 6 minutes ago

ALLR new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/6/8/wcwbnIMG_8648.gif

oldstocks

oldstocks 6 minutes ago

Nvidia Corporation NVDA, It is a softwareand fabless company which designs and supplies graphics processing units (GPUs), application programming interfaces (APIs) for data science and high-performance computing, as well as system on a chip units (SoCs) for the mobile computing and automotive market

mo_doggie

mo_doggie 7 minutes ago

The guy talking on your video here is hard to understand because of his accent. I think he said the price needs to hold at $26 in order to rebound. Is that correct? Thanks much!

Boing x 2

Boing x 2 7 minutes ago

And so it starts. End of the Fed. About time,

"https://silverseek.com/article/supreme-court-ruling-state-sponsored-banks-can-disband-federal-reserve-system-and-issue"

Boing X 2

Eppo

Eppo 8 minutes ago

This Question is for MisterLebby: Tell me Michael why you bring your stakeholders in such much sadness. We are following LWL for sometimes more than 10 years and watch the price now 2,54...you promise time in time deals but till this moment nothing happened...i ask you now from man too man: are you

extrooper

extrooper 8 minutes ago

Well said newman2021 ! DCVax platform is well positioned to make a huge difference in oncology

KCCO7913

KCCO7913 8 minutes ago

Don’t assume Ted! Haha

Hi_Lo

Hi_Lo 8 minutes ago

It doesn't make sense to me that the sec would hold responsible the new owner of a company for the misdeeds of past mgmt. I would think the restitution and remedy would be expected from the past mgmt. Something's not right here.
You really don't understand how SEC enforcement works. They look

silkmaster

silkmaster 8 minutes ago

0.132$ -> 1.00$ ETA EOM 06/2024 pre Igotthemojo imo.
Thats 15 trade days imo.
I hope huge news will come by then to support your target Igotthemojo .

AgentQ

AgentQ 9 minutes ago

Yup.. if they execute the roadmap, show the revenues , and complete share cancellation all which I anticipate will happen we should be well above .10

tedpeele

tedpeele 9 minutes ago

Marcelli's word is untrustworthy. nuff said.

ulmadi

ulmadi 10 minutes ago

I think your lies are much bigger than Henry's.
Go HENRY - Go PHIL

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions